Family Medicine pp 1262-1296 | Cite as

Blood and the Hematopoietic System

  • William B. Herring


In this chapter the author has endeavored to define the concepts and skills pertaining to the broad specialty of hematology that should belong to the average family physician. Suggestions are offered for hematologic procedures in the office laboratory, for determining when consultation with a hematologist is indicated, and for the important role that the family physician should play in the care of patients with hematologic problems whose complexity requires a continuing role for the hematologist beyond that normally expected of a consultant. Because family physicians vary widely in their interest, experience, and competence in the field of hematology, I have chosen as my reference point that level of knowledge and skills that should be achieved in a residency program in family medicine.


Iron Deficiency Family Physician Iron Overload Aplastic Anemia Fresh Freeze Plasma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Williams WJ, Beutler E, Erslev AJ, and Rundles RW (eds.): Hematology. 2nd ed. New York, McGraw-Hill, 1977.Google Scholar
  2. 2.
    Wintrobe MM, Lee GR, Boggs DR, Bithell TC, Athens JW, and Foerster J (eds.): Clinical Hematology. 7th ed. Philadelphia, Lea & Febiger, 1974.Google Scholar
  3. 3.
    Izak G: Erythroid cell differentiation and maturation. Prog Hematol 10: 1–41, 1977.PubMedGoogle Scholar
  4. 4.
    Golde DW, Hocking WG, Koeffler HP, Adamson JW: Polycythemia: mechanisms and management. Ann Int Med 95: 71–87, 1981.PubMedCrossRefGoogle Scholar
  5. 5.
    Hershko C: Storage iron regulation. Prog Hematol 10: 105–148, 1977.PubMedGoogle Scholar
  6. 6.
    Halliday JW, Powell LW: Serum ferritin and isoferritins in clinical medicine. Prog Hematol 11: 229–266, 1979.PubMedGoogle Scholar
  7. 7.
    Lux SE: Spectrin-actin membrane skeleton of normal and abnormal red blood cells. Semin Hematol 16: 2151, 1979.Google Scholar
  8. 8.
    Cooper RA: Hemolytic syndromes and red cell membrane abnormalities in liver disease. Semin Hematol 17: 103–112, 1980.PubMedGoogle Scholar
  9. 9.
    Lorand L, Seifring GE Jr, Lowe-Krentz L: Enzymatic basis of membrane stiffening in human erythrocytes. Semin Hematol 16: 65–74, 1979.PubMedGoogle Scholar
  10. 10.
    Mohandas N, Phillips WM, Bessis M: Red blood cell deformability and hemolytic anemia. Semin Hematol 16: 95–114, 1979.PubMedGoogle Scholar
  11. 11.
    Brown EB: Acute hemorrhagic anemia. In: Beeson PD, McDermott W, Wyngaarden JR (eds.) Cecil Textbook of Medicine. 15th ed. Philadelphia, Saunders, 17291730, 1979.Google Scholar
  12. 12.
    Wintrobe MM: The volume and hemoglobin content of the red blood corpuscle: Simple method of calculation, normal findings, and value of such calculations in the anemias. Am J Med Sci 177: 513–523, 1929.CrossRefGoogle Scholar
  13. 13.
    England JM, Walford DM, Waters DAW: Reassessment of the reliability of the hematocrit. Br J Haematol 23: 247–256, 1972.PubMedCrossRefGoogle Scholar
  14. 14.
    Gottfried EL: Erythrocyte indexes with the electronic counter. N Engl J Med 300: 1277, 1979.PubMedGoogle Scholar
  15. 15.
    Rose MS: Epitaph for the MCHC. Br Med J 4: 169, 1971.PubMedCrossRefGoogle Scholar
  16. 16.
    Herbert V: Megaloblastic anemias. In: Beeson PD, McDermott W, Wyngaarden JR (eds.) Cecil Textbook of Medicine. 15th ed. Philadelphia, Saunders, 17191729, 1979.Google Scholar
  17. 17.
    Halstead CH: Intestinal absorption and malabsorption of folates Ann Rev Med 31: 79–87, 1980.CrossRefGoogle Scholar
  18. 18.
    Lindenbaum J: Folate and vitamin B12 deficiencies in alcoholism. Semin Hematol 17: 119–129, 1980.PubMedGoogle Scholar
  19. 19.
    Waxman S: Folate-binding proteins. Br J Haematol 29: 23–29, 1975.PubMedCrossRefGoogle Scholar
  20. 20.
    Crosby WH: Pica. JAMA 235: 2765, 1976.Google Scholar
  21. 21.
    Roselle HA: Association of laundry starch and drug ingestion with anemia in New York City. Arch Intern Med 125: 57–61, 1970.PubMedCrossRefGoogle Scholar
  22. 22.
    Blum M, Orton CG, Rose L: The effect of starch ingestion on excessive iron absorption. Ann Int Med 68: 1165, 1968.Google Scholar
  23. 23.
    Maravilla AM, Berk RN: The radiographic diagnosis of pica. Am J Gastroenterol 70: 94–99, 1978.PubMedGoogle Scholar
  24. 24.
    Albahary C: Lead and hemopoiesis. Am J Med 52: 367378, 1972.Google Scholar
  25. 25.
    Benz EJ, Forget BG: The molecular genetics of the thalassemia syndromes. Prog Hematol 9: 107–155, 1975.PubMedGoogle Scholar
  26. 26.
    Pearson HA, O’Brien RT, McIntosh S: Screening for thalassemia trait by electronic measurement of mean corpuscular volume. N Engl J Med 288: 351–353, 1973.PubMedCrossRefGoogle Scholar
  27. 27.
    Pearson HA, RT O’Brien: The management of thalassemia major. Semin Hematol 12: 255–265, 1975.PubMedGoogle Scholar
  28. 28.
    Cartwright GE, Deiss A: Sideroblasts, siderocytes, and sideroblastic anemia. N Engl J Med 292: 185–193, 1975.PubMedCrossRefGoogle Scholar
  29. 29.
    Hines JD, Grasso JA: The sideroblastic anemias. Semin Hematol 7: 86–106, 1970.PubMedGoogle Scholar
  30. 30.
    Bottomley SS: Porphyrin and iron metabolism in sideroblastic anemia. Semin Hematol 14: 169–185, 1977.PubMedGoogle Scholar
  31. 31.
    Buchanan GR, Bottomley SS, Nitschke R: Bone marrow delta-aminolevulinate synthase deficiency in a female with congenital sideroblastic anemia. Blood 55: 109–115, 1980.PubMedGoogle Scholar
  32. 32.
    Hines JD: Effect of pyridoxine plus chronic phlebotomy on the function and morphology of bone marrow and liver in pyridoxine-responsive sideroblastic anemia. Semin Hematol 13: 133–140, 1976.PubMedGoogle Scholar
  33. 33.
    Personal observations.Google Scholar
  34. 34.
    Cheng DS, Kushner JP, Wintrobe MM: Idiopathic re fractory sideroblastic anemia. Cancer 44: 724–731, 1979.PubMedCrossRefGoogle Scholar
  35. 35.
    Bowman WD Jr: Abnormal (“ringed”) sideroblasts in various hematologic and nonhematologic disorders. Blood 18: 662–671, 1961.PubMedGoogle Scholar
  36. 36.
    Jacobs A: Iron overload-clinical and pathological aspects. Semin Hematol 14: 89–113, 1977.PubMedGoogle Scholar
  37. 37.
    Boggs DR: The hematopoietic microenvironment. N Engl J Med 302: 1359–1360, 1980.PubMedCrossRefGoogle Scholar
  38. 38.
    Williams DM, Lynch RE, Cartwright GE: Drug-induced aplastic anemia. Semin Hematol 10: 195–223, 1975.Google Scholar
  39. 39.
    Speck B, Gluckman E, Haak HL, Van Rood JJ: Treatment of aplastic anemia by antilymphocyte globulin with or without marrow infusion. Clin Haematol 7: 611–621, 1978.PubMedGoogle Scholar
  40. 40.
    Buckner CD, Cliff RA, Fefer A, Neiman P, Storb R, Thomas ED: Human marrow transplantation-current status. Prog Hematol 8: 299–324, 1975.Google Scholar
  41. 41.
    Storb R, Prentice RL, Thomas ED: Marrow transplantation for treatment of aplastic anemia. N Engl J Med 296: 61–66, 1977.PubMedCrossRefGoogle Scholar
  42. 42.
    Zeok JV, Todd EP, Dillon M, DeSimone P, Utley JR: The role of thymectomy in red cell aplasia. Ann Thorac Surg 28: 257–260, 1979.PubMedCrossRefGoogle Scholar
  43. 43.
    Ershler WB, Ross J, Finlay JL, Shahidi NT: Bone-marrow microenvironment defect in congenital hypoplastic anemia. N Engl J Med 302: 1321–1327, 1980.PubMedCrossRefGoogle Scholar
  44. 44.
    Krantz SB: Pure red cell aplasia. Br J Haematol 25: 16, 1973.CrossRefGoogle Scholar
  45. 45.
    Messner HA, Fauser AA, Curtis JE, Dolten D: Control of antibody mediated pure red cell aplasia by plasmapheresis. N Engl J Med 304: 1334–1338, 1981.PubMedCrossRefGoogle Scholar
  46. 46.
    Groopman JE: The pathogenesis of myelofibrosis in myeloproliferative disorders. Ann Intern Med 92: 857858, 1980.Google Scholar
  47. 47.
    Ward HP, Block MG: The natural history of agnogenic myeloid metaplasia (AMM) and a critical evaluation of its relationship with the myeloproliferative syndrome. Medicine 50: 357–420, 1971.PubMedCrossRefGoogle Scholar
  48. 48.
    Lewis SM, Verwilghen RL: Dyserythropoiesis and dyserythropoietic anemias. Prog Hematol 8: 99–129, 1973.PubMedGoogle Scholar
  49. 49.
    Cartwright GE, Lee GR: The anemia of chronic disorders. Br J Haematol 21: 147–152, 1971.PubMedCrossRefGoogle Scholar
  50. 50.
    Tauber AI: Current views of neutrophil dysfunction; An integrated clinical perspective. Am J Med 70: 1237 1246, 1981.Google Scholar
  51. 51.
    Adams EB: Anemia associated with protein deficiency. Semin Hematol 7: 55–66, 1970.PubMedGoogle Scholar
  52. 52.
    Nagel RL, Bookchin RM: Human hemoglobin mutants with abnormal oxygen binding. Semin Hematol 11: 385–403, 1974.PubMedGoogle Scholar
  53. 53.
    Schilling RF: Hereditary spherocytosis. A study of splenectomized persons. Semin Hematol 13: 169–176, 1976.PubMedGoogle Scholar
  54. 54.
    Powars DR: Natural history of sickle cell disease. Semin Hematol 12: 267–285, 1975.PubMedGoogle Scholar
  55. 55.
    Barrett-Conner E: Bacterial infection and sickle cellanemia. An analysis of 250 infections in 166 patients and a review of the literature. Medicine 50: 97–112, 1971.Google Scholar
  56. 56.
    Gavrilis P, Rothenberg SP, Guy R: Correlation of low serum IgM levels with absence of functional splenic tissue in sickle cell disease syndromes. Am J Med 57: 542–545, 1974.PubMedCrossRefGoogle Scholar
  57. 57.
    Jones SR, Binder RA, Donowho EM Jr: Sudden death in sickle cell trait. N Engl J Med 282: 323–325, 1970.PubMedCrossRefGoogle Scholar
  58. 58.
    Charache S: Treatment of sickle cell anemia. Ann Rev Med 32: 195–206, 1981.PubMedCrossRefGoogle Scholar
  59. 59.
    Harkness DR, Roth S: Clinical evaluation of cyanate in sickle cell anemia. Prog Hematol 9: 157–184, 1975.PubMedGoogle Scholar
  60. 60.
    Beutler E: A series of new screening procedures for pyruvate kinase deficiency, glucose-6-phosphate dehydrogenase deficiency, and glutathione reductase deficiency. Blood 28: 553–562, 1966.PubMedGoogle Scholar
  61. 61.
    Gilliland BC: Coombs-negative immune hemolytic anemia. Semin Hematol 13: 267–275, 1976.PubMedGoogle Scholar
  62. 62.
    Lange RL: Erythrocytosis associated with normal blood-gas values. Adv Intern Med 21: 309–335, 1976.PubMedGoogle Scholar
  63. 63.
    Sagone AL Jr, Balcerzak SP: Smoking as a cause of erythrocytosis. Ann Intern Med 82: 512–515, 1975.PubMedCrossRefGoogle Scholar
  64. 64.
    Edwards CQ, Cartwright GE, Skolnick MH, Amos DB: Homozygosity for hemochromatosis: Clinical manifestations. Ann Intern Med 93: 519–532, 1980.PubMedCrossRefGoogle Scholar
  65. 65.
    Herring WB, Gay RM: Absence of stainable bone marrow iron in hemochromatosis. South Med J 74: 1088 1089, 1981.Google Scholar
  66. 66.
    Conn HO: Portacaval anastomosis and hepatic hemosiderin deposition: A prospective controlled investigation. Gastroenterology 62: 61–72, 1972.PubMedGoogle Scholar
  67. 67.
    Bassett ML, Halliday JW, Powell LW: Her, ochromatosis-newer concepts: Diagnosis and manage. Went. DM 26: 1–44, 1980.Google Scholar
  68. 68.
    Modell B: Advances in the use of iron-chelating agents for the treatment of iron overload. Prog Hematol 11: 267–312, 1979.PubMedGoogle Scholar
  69. 69.
    Goldberg A, Moore MR (eds.) The porphyrias. Clin Haematol 9:225–451, 1980.Google Scholar
  70. 70.
    Robinson WA, Mangalik A: The kinetics and regulation of granulopoiesis. Semin Hematol 12: 7–25, 1975.PubMedGoogle Scholar
  71. 71.
    Craddock PR, Hammerschmidt DE, Moldow CF, Yamada O, Jacob HS: Granulocyte aggregation as a manifestation of membrane interactions with complement: Possible role in leukocyte margination, micro-vascular occlusion, and endothelial damage. Semin Hematol 16: 140–147, 1979.PubMedGoogle Scholar
  72. 72.
    Quie PG: Pathology of bactericidal power of neutrophils. Semin Hematol 12: 143–160, 1975.PubMedGoogle Scholar
  73. 73.
    Sullivan TJ: The role of eosinophils in inflammatory reactions. Prog Hematol 11: 65–82, 1979.PubMedGoogle Scholar
  74. 74.
    Griffin JG, Cochrane CG:. Recent advances in the understanding of contact, activation reactions. Semin Thromb Hemostas 5: 254–273, 1979.Google Scholar
  75. 75.
    Dvorak HF, Dvorak AM: Basophilic leukocytes: structure, function and role in disease. Clin Haematol 4: 651–683, 1975.PubMedGoogle Scholar
  76. 76.
    Kay NF, Ackerman SK, Douglas SD: Anatomy of the immune system. Semin Hematol 16: 252–282, 1979.PubMedGoogle Scholar
  77. 77.
    Shearer WT, Mitchell PF: Immune surveillance system: Its failure and activation. Prog Hematol 10: 247310, 1977.Google Scholar
  78. 78.
    Barton JC: Nonhemolytic, noninfectious transfusion reactions. Semin Hematol 18: 95–121, 1981.PubMedGoogle Scholar
  79. 79.
    Moore RA, Brunner CM, Sandusky WR, Leavell BS: Felty’s syndrome: Long-term follow-up after splenectomy. Ann Intern Med 75: 381–385, 1971.PubMedCrossRefGoogle Scholar
  80. 80.
    Hagler L, Pastore RA, Bergin JJ: Aplastic anemia following viral hepatitis. Medicine 54: 139–164, 1975.PubMedGoogle Scholar
  81. 81.
    Pisciotta AV: Immune and toxic mechanisms in drug-induced agranulocytosis. Semin Hematol 10: 279–310, 1973.PubMedGoogle Scholar
  82. 82.
    Logue GL, Shimm DS: Autoimmune granulocytopenia. Ann Rev Med 31: 191–200, 1980.PubMedCrossRefGoogle Scholar
  83. 83.
    Sawitsky A (ed.): Reticuloendothelial disorders: the lipidoses. Semin Hematol 9:225–453, 1972.PubMedGoogle Scholar
  84. 84.
    Lichtman MA (ed.): Hematology for Clinicians. Boston, Little-Brown, 1978.Google Scholar
  85. 85.
    Utsinger PD: Lymphocyte changes in viral infections. Ann Intern Med 83: 82, 1975.PubMedCrossRefGoogle Scholar
  86. 86.
    Zacharski LR, Linman JW: Lymphocytopenia: its causes and significance. Mayo Clin Proc 46: 168–173, 1971.PubMedGoogle Scholar
  87. 87.
    Malpass TW, Harker LA: Acquired disorders of platelet function. Semin Hematol 17: 242–258, 1980.PubMedGoogle Scholar
  88. 88.
    Miescher PA: Drug-induced thrombocytopenia. Semin Hematol 10: 311–325, 1973.PubMedGoogle Scholar
  89. 89.
    Ahn YS, Harrington WJ: Treatment of idiopathic thrombocytopenic purpura (ITP). Ann Rev Med 28: 299–309, 1977.PubMedCrossRefGoogle Scholar
  90. 90.
    Czapek EE, Deykin D, Salzman E, Lian EC, Hellerstein LJ, Rosoff CB: Intermediate syndrome of platelet dysfunction. Blood 52: 103–113, 1978.PubMedGoogle Scholar
  91. 91.
    Weiss HJ: Congenital disorders of platelet function. Semin Hematol 17: 228–241, 1980.PubMedGoogle Scholar
  92. 92.
    Bachman F: Diagnostic approach to mild bleeding disorders. Semin Hematol 17: 292–305, 1980.Google Scholar
  93. 93.
    Weiss L, Tavassoli M: Anatomical hazards to the passage of erythrocytes through the spleen. Semin Hematol 7: 372–380, 1970.PubMedGoogle Scholar
  94. 94.
    Brain MC: Hazards of splenectomy. In: Nathan DG, Oski FA (eds.) Hematology of Infancy and Childhood, Philadelphia, Saunders, 248–249, 1974.Google Scholar
  95. 95.
    Zuelzer WW, Kaplan J: The child with lymphadenopathy. Semin Hematol 12: 323–334, 1975.PubMedGoogle Scholar
  96. 96.
    Lowe GDO, Forbes CD: Laboratory diagnosis of coagulation defects. Clin Haematol 8: 79–94, 1979.PubMedGoogle Scholar
  97. 97.
    Nydegger VE, Miescher PA: Bleeding due to vascular disorders. Semin Hematol 17: 178–191, 1980.PubMedGoogle Scholar
  98. 98.
    Smith JK, Bidwell E: Therapeutic materials in the treatment of coagulation defects. Clin Hematol 8: 183214, 1979.Google Scholar
  99. 99.
    Lewis JL, Spero JA, Hasiba V: Coagulopathies. DM 23: 1–64, 1977.Google Scholar
  100. 100.
    Abildgaard CF: Current concepts in the management of hemophilia. Semin Hematol 12: 223–232, 1975.PubMedGoogle Scholar
  101. 101.
    Janson PA, Jubeliver SJ, Weinstein MJ, Deykin D: Treatment of bleeding tendency in uremia with cryo-Google Scholar
  102. precipitate. N Engl J Med 303: 1318–1322, 1980.CrossRefGoogle Scholar
  103. 102.
    Corrigan JJ: Heparin therapy in bacterial septicemia. J Pediatr 91: 695–700, 1977.PubMedCrossRefGoogle Scholar
  104. 103.
    Colman RW, Robboy SJ, Minna JD: Disseminated intravascular coagulation: a reappraisal. Ann Rev Med 30: 359–374, 1979.PubMedCrossRefGoogle Scholar
  105. 104.
    Harker LA: Hemostatis Manual. 2nd ed. Philadelphia, FA Davis, 1974.Google Scholar
  106. 105.
    Roberts HR: Personal communication. Borucki DT: Blood Component Therapy. 3rd ed. Washington, Am Assoc Blood Banks, 1981.Google Scholar
  107. 106.
    Vogler WR, Winton EF: A controlled study of the efficacy of granulocyte transfusions in patients with neutropenia. Am J Med 63: 548–555, 1977.PubMedCrossRefGoogle Scholar
  108. 107.
    Cash JD (ed.): Blood transfusion and blood products. Clin Haematol 5:1–226, 1976.Google Scholar
  109. 108.
    Greenwald, TJ: Pathogenesis and management of hemolytic transfusion reactions. Semin Hematol 18: 8494, 1981.Google Scholar

Copyright information

© Springer Science+Business Media New York 1983

Authors and Affiliations

  • William B. Herring

There are no affiliations available

Personalised recommendations